Evid Invest

Earnings calendar/FBLG

FibroBiologics, Inc. (FBLG)

Quarter-by-quarter results read from the company's own filed statements — period end, filing date, diluted EPS, revenue and year-over-year change. Consensus estimates are shown only where one exists.

Latest filed quarter

The most recent quarter FibroBiologics, Inc. has filed, from EvidInvest's standardized statements.

Period end

Jun 30, 2026

Q2 FY2026

Filed

Jul 31, 2026

View the filing

EPS (diluted)

$-0.66

Est. $-0.93 · +29.0%

Revenue

$0

As filed

Net income

$-4.1M

As filed

EPS YoY

+72.6%

vs quarter ended 2025-06-30

Revenue YoY

vs quarter ended 2025-06-30

Next report

Oct 30, 2026

Scheduled · est. EPS $-0.63

Run-rate

Trailing twelve months, summed from the last four filed quarters.

TTM EPS (diluted)

$-5.27

2025-09-30 through 2026-06-30

TTM revenue

$0

2025-09-30 through 2026-06-30

Filed quarters

18

On record here

EPS at or above estimate (4Q)

50%

Of the last four quarters that carry an estimate

Filed quarters

One row per filed statement, newest first

Period endFiledEPS dilutedRevenueEPS YoYRevenue YoYEst. EPSSurprise
2026-06-30Q2 FY20262026-07-31$-0.66$0+72.6%$-0.93+29.0%
2026-03-31Q1 FY20262026-04-30$-1.33$0+50.9%$-1.26-5.6%
2025-12-31Q4 FY20252026-02-24$-0.68$0+62.2%$-1.44+52.8%
2025-09-30Q3 FY20252025-10-31$-2.60$0-1200.0%$-2.00-30.0%
2025-06-30Q2 FY20252025-07-31$-2.41$0-501.7%$-0.11-2090.9%
2025-03-31Q1 FY20252025-05-14$-2.71$0+49.8%$-0.10-2610.0%
2024-12-31Q4 FY20242025-03-31$-1.80$0+73.5%$-0.10-1700.0%
2024-09-30Q3 FY20242024-11-12$-0.20$0+87.5%$-1.44+86.2%
2024-06-30Q2 FY20242024-08-07$0.60$0+137.5%$-0.09+766.7%
2024-03-31Q1 FY20242024-05-14$-5.40$0-50.0%
2023-12-31Q4 FY20232024-02-29$-6.80$0-13500.0%
2023-09-30Q3 FY20232024-11-12$-1.60$0-3100.0%
2023-06-30Q2 FY20232024-08-07$-1.60$0-3900.0%
2023-03-31Q1 FY20232024-05-14$-3.60$0-8900.0%
2022-12-31Q4 FY20222022-12-31$-0.05$0
2022-09-30Q3 FY20222022-09-30$-0.05$0
2022-06-30Q2 FY20222022-06-30$-0.04$0
2022-03-31Q1 FY20222022-03-31$-0.04$0
EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.